Figure 2.
Quantification of ViraChip® units IgA/IgG anti‐S1, S2, and N antigens in 38 hospitalized volunteers according to patient's outcome (recovered or deceased). Analysis based on the maximal quantification obtained for each parameter
Quantification of ViraChip® units IgA/IgG anti‐S1, S2, and N antigens in 38 hospitalized volunteers according to patient's outcome (recovered or deceased). Analysis based on the maximal quantification obtained for each parameter